The purpose of the Boston University Alzheimer's Disease Core Center (BU) ADCC) is to promote research concerning Alzheimer's Disease (AD) at Boston University and throughout the country by providing information and materials from well characterized and unique patient and caregiver populations: the ambulatory and late-stage suburban population at the Bedford VA Medical Center and the racially, ethnically, and culturally diverse poor urban population served by the Boston University Hospital Home Medical Service (HMS). All patients enrolled in the Clinical Core will be assessed every six months with a comprehensive neuropsychological test battery. A neurological examination will be performed annually and blood will be obtained to isolate DNA for molecular genetic studies and stored. A detailed family history will be obtained and caregivers will be assessed yearly. The database will allow for longitudinal comparisons and the ability to correlate the progression of AD with its impact on caregivers. The Neuropathology Core will establish accurate pathological diagnoses, rigorous documentation and quantitation of neuropathological changes, produce endothelial cell lines, and collect, store and disburse postmortem tissues. The Education and Information Transfer Core will provide a comprehensive program of AD research development, dissemination, and utilization for professional caregivers with respect to symptom management. The BU ADCC will fund pilot projects to promote new AD research and foster the development of new AD investigators. The BU ADCC will closely cooperate with, and complement, the Massachusetts Alzheimer's Disease Research Center and other national Alzheimer centers. These multiple activities will be coordinated by the Administrative Core. Research in AA at Boston University is substantial in all areas, from basic molecular biology through health services research. The ADCC will strengthen existing research and create new research alliances across BU sites. It will greatly facilitate basic research on the pathogenesis of AD, applied research on patient management strategies, and research concerning the impact of disease burden on caregivers and society. In addition, it will help foster the integration of basic and applied research to better understand the biological basis of clinical symptoms.

Agency
National Institute of Health (NIH)
Institute
National Institute on Aging (NIA)
Type
Center Core Grants (P30)
Project #
5P30AG013846-05
Application #
6168827
Study Section
Special Emphasis Panel (ZAG1-DAG-4 (30))
Program Officer
Phelps, Creighton H
Project Start
1996-07-01
Project End
2001-06-30
Budget Start
2000-08-01
Budget End
2001-06-30
Support Year
5
Fiscal Year
2000
Total Cost
$969,101
Indirect Cost
Name
Boston University
Department
Neurology
Type
Schools of Medicine
DUNS #
604483045
City
Boston
State
MA
Country
United States
Zip Code
02118
Alosco, Michael L; Sugarman, Michael A; Besser, Lilah M et al. (2018) A Clinicopathological Investigation of White Matter Hyperintensities and Alzheimer's Disease Neuropathology. J Alzheimers Dis 63:1347-1360
Cherry, Jonathan D; Mez, Jesse; Crary, John F et al. (2018) Variation in TMEM106B in chronic traumatic encephalopathy. Acta Neuropathol Commun 6:115
Brent, Robert J (2018) Estimating the monetary benefits of medicare eligibility for reducing the symptoms of dementia. Appl Econ 50:6327-6340
Deming, Yuetiva; Dumitrescu, Logan; Barnes, Lisa L et al. (2018) Sex-specific genetic predictors of Alzheimer's disease biomarkers. Acta Neuropathol 136:857-872
Li, Dan; Wang, Lei; Maziuk, Brandon F et al. (2018) Directed evolution of a picomolar-affinity, high-specificity antibody targeting phosphorylated tau. J Biol Chem 293:12081-12094
Crum, Jana; Wilson, Jeffrey; Sabbagh, Marwan (2018) Does taking statins affect the pathological burden in autopsy-confirmed Alzheimer's dementia? Alzheimers Res Ther 10:104
Tagge, Chad A; Fisher, Andrew M; Minaeva, Olga V et al. (2018) Concussion, microvascular injury, and early tauopathy in young athletes after impact head injury and an impact concussion mouse model. Brain 141:422-458
Petyuk, Vladislav A; Chang, Rui; Ramirez-Restrepo, Manuel et al. (2018) The human brainome: network analysis identifies HSPA2 as a novel Alzheimer’s disease target. Brain 141:2721-2739
Tse, Kai-Hei; Cheng, Aifang; Ma, Fulin et al. (2018) DNA damage-associated oligodendrocyte degeneration precedes amyloid pathology and contributes to Alzheimer's disease and dementia. Alzheimers Dement 14:664-679
Burke, Shanna L; Cadet, Tamara; Maddux, Marlaina (2018) Chronic Health Illnesses as Predictors of Mild Cognitive Impairment Among African American Older Adults. J Natl Med Assoc 110:314-325

Showing the most recent 10 out of 791 publications